Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Disease-specific molecular events in cortical multiple sclerosis lesions.
Downbeat nystagmus associated with damage to the medial longitudinal fasciculus of the pons: A vestibular balance control mechanism via the lower brainstem paramedian tract neurons.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Prospective Evaluation of Laparoscopic Assisted Cystectomy and Ileal Conduit in Advanced Multiple Sclerosis.
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model.
[Neuromyelitis optica in children. Two case reports.]
Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin.
Role of vitamin D in regulating the neural stem cells of mouse model with multiple sclerosis.
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
A new therapeutic target for the treatment of multiple sclerosis.
Long-term benefits of induction therapy in NMO: a case report.
Exome sequencing to find rare variants causing neurologic diseases.
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Cognitive reserve in multiple sclerosis: Protective effects of education.
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
Estimating typical multiple sclerosis disability progression speed from clinical observations.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
Early accurate diagnosis crucial in multiple sclerosis.
Pathology of multiple sclerosis: where do we stand?
Pages
« first
‹ previous
…
269
270
271
272
273
274
275
276
277
…
next ›
last »